Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance | Zendy

Seung Young Seo | Zendy; In Hee Kim | Zendy; Jungwoo Sohn | Zendy; Seok Lee | Zendy; Seong Hun Kim | Zendy; Sang Wook Kim | Zendy; Seung Ok Lee | Zendy; Soo Teik Lee | Zendy; Dae-Ghon Kim | Zendy

Open Access

Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance

Author(s) -

Seung Young Seo,

In Hee Kim,

Jungwoo Sohn,

Seok Lee,

Seong Hun Kim,

Sang Wook Kim,

Seung Ok Lee,

Soo Teik Lee,

Dae-Ghon Kim

Publication year - 2013

Publication title -

intervirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.641

H-Index - 61

eISSN - 1423-0100

pISSN - 0300-5526

DOI - 10.1159/000353851

Subject(s) - entecavir , adefovir , lamivudine , medicine , gastroenterology , refractory (planetary science) , combination therapy , hepatitis b , hepatitis b virus , chronic hepatitis , group b , virology , virus , biology , astrobiology

We investigated the long-term efficacy of entecavir (ETV) + adefovir (ADV) combination therapy versus ETV monotherapy in lamivudine (LAM)-resistant chronic hepatitis B (CHB) patients who failed to respond to ADV rescue therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research